Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options
Erly, Brian , Carey, William, Kapoor, Baljendra , McKinney, J. Mark , Tam, Mathew, Wang, Weiping , Wang, Weiping

Mayo Clinic

Seminars in Interventional Radiology | November 10, 2015 | Volume: 32 | Issue: 04 | Pages: 445-454

10.1055/s-0035-1564794 | PMID 26622108 Get It

A randomized trial comparing multiband mucosectomy and cap-assisted endoscopic resection for endoscopic piecemeal resection of early squamous neoplasia of the esophagus
Zhang, Yue-Ming, Boerwinkel, David F., Qin, Xiumin, He, Shun , Xue, Liyan , Weusten, Bas L. , Fleischer, David E., Dou, Lizhou, Lü, Ning , Bergman, Jacques , Wang, Gui-Qi, Dawsey, Sanford M. , Liu, Yong

Mayo Clinic

Endoscopy | November 6, 2015 | Volume: 48 | Issue: 04 | Pages: 330-338

10.1055/s-0034-1393358 | PMID 26545174 Get It

Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo
Aredo, Bogale, Zhong, Xin , Pulido, José S. , Wang, Shusheng , He, Yu-Guang, Huang, Xianming , Brekken, Rolf A. , Ufret-Vincenty, Rafael , Li, Tao , Zhang, Kaiyan

Mayo Clinic

Investigative Opthalmology & Visual Science | November 3, 2015 | Volume: 56 | Issue: 12 | Pages: 7137

10.1167/iovs.15-17302 | PMID 26529048 Get It

Is Exposure to Famine in Childhood and Economic Development in Adulthood Associated With Diabetes?
Wang, Ningjian , Wang, Xiaojin , Han, Bing , Li, Qin , Chen, Yi , Chen, Yingchao , Xia, Fangzhen , Cang, Zhen, Zhu, Chaoxia , Lu, Meng , Lin, Dongping, Wang, Bingshun , Jensen, Michael D. , Lu, Yingli , Zhu, Chunfang, Meng, Ying , Chen, Chi , Zhu, Chunfang , Meng, Ying

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 28, 2015 | Volume: 100 | Issue: 12 | Pages: 4514-4523

10.1210/jc.2015-2750 | PMID 26509871 Get It

Dimeric bis (heptyl)‐Cognitin Blocks Alzheimer's β‐Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils
Hu, Shengquan, Cui, Wei , Mak, Shinghung , Y, Hu , Lee, Ming‐Yuen, Pang, Yuan‐Ping , Han, Yifan , Wang, Rui Ting , Li, Gang , Lee, Ming‐Yuen, Han, Yifan , Pang, Yuan-Ping

Mayo Clinic

CNS Neuroscience & Therapeutics | October 28, 2015 | Volume: 21 | Issue: 12 | Pages: 953-961

10.1111/cns.12472 | PMID 26507365 Get It

SummaryAimsFibrillar aggregates of β‐amyloid protein (Aβ) are the main constituent of senile plaques and considered to be one of the causative events in the pathogenesis of Alzheimer's disease (AD). Compounds that could inhibit Aβ fibrils formation, disaggregate preformed Aβ fibrils as well as reduce their associated neurotoxicity might have therapeutic values for treating AD. In this study, the inhibitory effects of bis (heptyl)‐cognitin (B7C), a multifunctional dimer derived from tacrine, on aggregation and neurotoxicity of Aβ1‐40 were evaluated both in vitro and in vivo.MethodsThioflavin T fluorescence assay was carried out to evaluate Aβ aggregation, MTT and Hoechst‐staining assays were performed to investigate Aβ‐associated neurotoxicity. Fluorescent probe DCFH‐DA was used to estimate the accumulation of intracellular reactive oxygen stress (ROS). Morris water maze was applied to determine learning and memory deficits induced by intracerebroventricular infusion of Aβ in rats.ResultsB7C (0.1–10 μM), but not tacrine, effectively inhibited Aβ fibrils formation and disaggregated preformed Aβ fibrils following co‐incubation of B7C and Aβ monomers or preformed fibrils, respectively. In addition, B7C markedly reduced Aβ fibrils‐associated neurotoxicity in SH‐SY5Y cell line, as evidenced by the increase in cell survival, the decrease in Hoechst‐stained nuclei and in intracellular ROS. Most encouragingly, B7C (0.1 and 0.2 mg/kg), 10 times more potently than tacrine (1 and 2 mg/kg), inhibited memory impairments after intracerebroventricular infusion of Aβ in rats, as evidenced by the decrease in escape latency and the increase in the spatial bias in Morris water maze test along with upregulation of choline acetyltransferase activity and downregulation of acetylcholinesterase activity.ConclusionThese findings provide not only novel molecular insight into the potential application of B7C in treating AD, but also an effective approach for screening anti‐AD agents.
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
Wang, Dejie , Ding, Liya , Wang, Liguo , Sun, Zhifu , Karnes, R. Jeffrey , Zhang, Jun , Zhao, Yu , Zhang, Jun, Huang, Haojie , Sun, Zhifu , Wang, Liguo

Mayo Clinic

Oncotarget | October 28, 2015 | Volume: 6 | Issue: 38 | Pages: 41045-41055

10.18632/oncotarget.5728 | PMID 26516927 Get It

Immature myeloid progenitors promote disease progression in a mouse model of Barrett's-like metaplasia
Kong, Jianping , Sai, Hong, Crissey, Mary Ann S. , Jhala, Nirag, Ginsberg, Gregory G. , Rustgi, Anil K. , Wang, Timothy C. , Falk, Gary W. , Abrams, Julian A , Nakagawa, Hiroshi , Wang, Kenneth , Lynch, John Patrick

Mayo Clinic

Oncotarget | October 25, 2015 | Volume: 6 | Issue: 32 | Pages: 32980-33005

10.18632/oncotarget.5431 | PMID 26460825 Get It

A pig‐to‐mouse coronary artery transplantation model for investigating the pathogenicity of anti‐pig antibody
Miyagi, Naoto, Byrne, Guerard W. , Du, Zeji , Kogelberg, Heide, Gazi, Mozammel H., Tazelaar, Henry D. , Wang, Chunsheng , McGregor, Christopher G.A. , Lin, Yi, Tazelaar, Henry D.

Mayo Clinic

Xenotransplantation | October 23, 2015 | Volume: 22 | Issue: 6 | Pages: 458-467

10.1111/xen.12198 | PMID 26490445 Get It

AbstractBackgroundRejection of Gal‐free (GTKO) donor pig cardiac xenografts is strongly associated with vascular non‐Gal antibody binding, endothelial cell (EC) injury, and activation and microvascular thrombosis. We adopted a pig‐to‐SCID/beige small animal transplant model to compare the pathogenicity of baboon and human anti‐pig antibody.MethodsWild‐type (GT+) or GTKO porcine coronary arteries (PCAs) were transplanted into the infrarenal aorta of SCID/beige mice. Three days after transplant, recipients were infused with anti‐pig antibody (anti‐SLA class I, an isotype control, naive or sensitized baboon serum, or naive human serum). PCAs were recovered 24 h after antibody infusion and examined using histology, immunohistochemistry, and in situ hybridization.ResultsDose‐dependent intragraft thrombosis occurred after infusion of anti‐SLA I antibody (but not isotype control) in GT+ and GTKO PCA recipients. Naive baboon serum induced thrombosis in GT+ grafts. Thrombosis was significantly reduced by pre‐treating naive baboon serum with Gal polymer and not observed when this serum was infused to GTKO PCA recipients. Naive human serum caused dose‐dependent intragraft thrombosis of GTKO PCAs. In all cases, thrombosis involved graft‐specific vascular antibody and complement deposition, macrophage adherence, EC delamination, and subendothelial thrombus formation.ConclusionsThis study provides the first direct in vivo comparison of the pathogenicity of naive human and baboon serum. The results suggest that human preformed non‐Gal antibody may have increased pathogenicity compared to baboon. This model, which showed a rejected graft histopathology similar to antibody‐mediated rejection in cardiac xenotransplantation, may be useful to assess the pathogenicity of individual protein or carbohydrate specific non‐Gal reactive antibodies.
Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas
Tesfaye, Anteneh , Hálfdánarson, Þorvarður R. , Wang, Jue , Gatalica, Zoran , Arguello, David, Smaglo, Brandon George , Meyer, Joshua E. , Reddy, Sandeep K. , Boland, Patrick M. , Halfdanarson, Thorvardur R

Mayo Clinic

Oncotarget | October 21, 2015 | Volume: 6 | Issue: 41 | Pages: 43594-43604

10.18632/oncotarget.6202 | PMID 26498363 Get It

Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease
Hwang, Young‐Hwan , Conklin, John , Roslin, Nicole M. , Liu, Jannel , He, Ning , Wang, Kairong , Sundsbak, Jamie L., Heyer, Christina M., Haider, Masoom A. , Paterson, Andrew D. , Harris, Peter C. , Pei, York , Chan, Winnie , Harris, Peter C , Paterson, Andrew

Mayo Clinic

Journal of the American Society of Nephrology | October 9, 2015 | Volume: 27 | Issue: 6 | Pages: 1861-1868

10.1681/asn.2015060648 | PMID 26453610 Get It

Renal disease variability in autosomal dominant polycystic kidney disease (ADPKD) is strongly influenced by the gene locus ( PKD1 versus PKD2 ). Recent studies identified nontruncating PKD1 mutations in approximately 30% of patients who underwent comprehensive mutation screening, but the clinical significance of these mutations is not well defined. We examined the genotype-renal function correlation in a prospective cohort of 220 unrelated ADPKD families ascertained through probands with serum creatinine ≤1.4 mg/dl at recruitment. We screened these families for PKD1 and PKD2 mutations and reviewed the clinical outcomes of the probands and affected family members. Height–adjusted total kidney volume (htTKV) was obtained in 161 affected subjects. Multivariate Cox proportional hazard modeling for renal and patient survival was performed in 707 affected probands and family members. Overall, we identified pathogenic mutations in 84.5% of our families, in which the prevalence of PKD1 truncating, PKD1 in–frame insertion/deletion, PKD1 nontruncating, and PKD2 mutations was 38.3%, 4.3%, 27.1%, and 30.3%, respectively. Compared with patients with PKD1 truncating mutations, patients with PKD1 in–frame insertion/deletion, PKD1 nontruncating, or PKD2 mutations have smaller htTKV and reduced risks (hazard ratio [95% confidence interval]) of ESRD (0.35 [0.14 to 0.91], 0.10 [0.05 to 0.18], and 0.03 [0.01 to 0.05], respectively) and death (0.31 [0.11 to 0.87], 0.20 [0.11 to 0.38], and 0.18 [0.11 to 0.31], respectively). Refined genotype-renal disease correlation coupled with targeted next generation sequencing of PKD1 and PKD2 may provide useful clinical prognostication for ADPKD.